The report will be delivered in 2-3 business days.

Alpha Mannosidosis Global Market Report 2021 - By Therapy Type (Bone Marrow Transplant (BMT), Enzyme Replacement Therapy (ERT), Peripheral Blood Stem Cell Transplantation (PBSCT), Gene Therapy), By Indication (Type I, Type II, Type III), By End-User (Hospitals, Speciality Clinics), COVID-19 Growth And Change

Starting Price : $5000.00 | Pages : 150 | Published : May 2021 | SKU CODE : | Format :


The alpha mannosidosis market consists of sales of therapies for alpha mannosidosis (organizations, sole traders and partnerships) that provides treatment for alpha mannosidosis, which is a lysosomal storage disorder. Lysosomes are particles bound in membranes within cells that function as the primary digestive units. Alpha-mannosidosis is a rare genetic inherited condition that affects the organs and tissues of the person suffering from the disease. The treatment therapy focuses on detecting and preventing polysaccharide accumulations within mutant cells, which can cause harm to tissue, organs, and eventually death. Polysaccharides are defined as larger molecules composed of several linked sugar molecules.

The main types of therapy for alpha mannosidosis are bone marrow transplant (BMT), enzyme replacement therapy (ERT), peripheral blood stem cell transplantation (PBSCT) and gene therapy. A bone marrow transplant is a procedure in which dysfunctional marrow is replaced with healthy marrow. Enzyme replacement therapy includes replacing a defective enzyme in people who are lacking or deficient in that enzyme. Peripheral blood stem cell transplantation is a procedure in which the patient whose stem cells that have been destroyed by disease or by the radiation or high doses of anticancer drugs, they receive healthy stem cells. Gene therapy is a procedure in when DNA is introduced into a patient to treat a genetic disease. The different types of indications include Type I, Type II and Type III and is implemented in wide range of verticals such as hospitals and specialty clinics.

The global alpha mannosidosis market is expected to grow from $7.50 million in 2020 to $8.89 million in 2021 at a compound annual growth rate (CAGR) of 18.6%. The growth is mainly due to increasing prevalence of alpha mannosidosis, use of orphan drugs, fee reductions and tax credits, increasing investment in the rare disease treatment and advancements in treatment drugs. The alpha mannosidosis market is expected to reach $17.91 million in 2025 at a CAGR of 19.1%.

The increasing investments on research is expected to contribute to the growth of the alpha mannosidosis market in the forecast period. Currently, in the alpha mannosidosis market, only one company has therapies for the rare genetic disease. However, several firms have products in the clinical stages, which will boost market demand in the forecast period. For instance, in 2020, the EU clinical trials database lists 39,219 clinical trials with a EudraCT protocol, 6,426 of which are clinical trials involving subjects under the age of 18. Therefore, the increasing investments on research fuels the growth of the alpha mannosidosis market.

The advancements in treatment for alpha mannosidosis like pharmacological therapy are gaining traction in the alpha mannosidosis market. For instance, in 2018 – Chiesi Group, an international research-focused Healthcare company, announced that it has received a positive opinion recommending the marketing authorization of Velmanase Alfa, under the brand name Lamzede from the European Medicines Agency Committee for Medicinal Products for Human Use. Lamzede is an enzyme replacement therapy intended to provide or supplement natural alpha-mannosidase, an enzyme that helps with the degradation of mannose–rich oligosaccharides and thus prevents their accumulation in various tissues in the body.

Major players in the alpha mannosidosis market are Chiesi Farmaceutici S.p.A., Nuo Therapeutics, and Zymenex.

North America was the largest region in the alpha mannosidosis market in 2020. Asia Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the alpha mannosidosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the alpha mannosidosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The global alpha mannosidosis market is segmented -

1) By Therapy Type: Bone Marrow Transplant (BMT), Enzyme Replacement Therapy (ERT), Peripheral Blood Stem Cell Transplantation (PBSCT), Gene Therapy

2) By Indication: Type I, Type II, Type III

3) By End-User: Hospitals, Speciality Clinics

    Table Of Contents

    1. Executive Summary

    2. Alpha Mannosidosis Market Characteristics

    3. Alpha Mannosidosis Market Trends And Strategies

    4. Impact Of COVID-19 On Alpha Mannosidosis

    5. Alpha Mannosidosis Market Size And Growth

    5.1. Global Alpha Mannosidosis Historic Market, 2015-2020, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Alpha Mannosidosis Forecast Market, 2020-2025F, 2030F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Alpha Mannosidosis Market Segmentation

    6.1. Global Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Bone Marrow Transplant (BMT)

    Enzyme Replacement Therapy (ERT)

    Peripheral Blood Stem Cell Transplantation (PBSCT)

    Gene Therapy

    6.2. Global Alpha Mannosidosis Market, Segmentation By Indication, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Type I

    Type II

    Type III

    6.3. Global Alpha Mannosidosis Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Hospitals

    Speciality Clinics

    7. Alpha Mannosidosis Market Regional And Country Analysis

    7.1. Global Alpha Mannosidosis Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    7.2. Global Alpha Mannosidosis Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    8. Asia-Pacific Alpha Mannosidosis Market

    8.1. Asia-Pacific Alpha Mannosidosis Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    9. China Alpha Mannosidosis Market

    9.1. China Alpha Mannosidosis Market Overview

    9.2. China Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

    10. India Alpha Mannosidosis Market

    10.1. India Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    11. Japan Alpha Mannosidosis Market

    11.1. Japan Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    12. Australia Alpha Mannosidosis Market

    12.1. Australia Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    13. Indonesia Alpha Mannosidosis Market

    13.1. Indonesia Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    14. South Korea Alpha Mannosidosis Market

    14.1. South Korea Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    15. Western Europe Alpha Mannosidosis Market

    15.1. Western Europe Alpha Mannosidosis Market Overview

    15.2. Western Europe Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    16. UK Alpha Mannosidosis Market

    16.1. UK Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    17. Germany Alpha Mannosidosis Market

    17.1. Germany Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    18. France Alpha Mannosidosis Market

    18.3. France Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    19. Eastern Europe Alpha Mannosidosis Market

    19.1. Eastern Europe Alpha Mannosidosis Market Overview

    19.2. Eastern Europe Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    20. Russia Alpha Mannosidosis Market

    20.1. Russia Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    21. North America Alpha Mannosidosis Market

    21.1. North America Alpha Mannosidosis Market Overview

    21.2. North America Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    22. USA Alpha Mannosidosis Market

    22.1. USA Alpha Mannosidosis Market Overview

    22.2. USA Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    23. South America Alpha Mannosidosis Market

    23.1. South America Alpha Mannosidosis Market Overview

    23.2. South America Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    24. Brazil Alpha Mannosidosis Market

    24.1. Brazil Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    25. Middle East Alpha Mannosidosis Market

    25.1. Middle East Alpha Mannosidosis Market Overview

    25.2. Middle East Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    26. Africa Alpha Mannosidosis Market

    26.1. Africa Alpha Mannosidosis Market Overview

    26.2. Africa Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    27. Alpha Mannosidosis Market Competitive Landscape And Company Profiles

    27.1. Alpha Mannosidosis Market Competitive Landscape

    27.2. Alpha Mannosidosis Market Company Profiles

    27.2.1. CHIESI Farmaceutici SpA

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Nuo Therapeutics

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Zymenex

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    28. Key Mergers And Acquisitions In The Alpha Mannosidosis Market

    29. Alpha Mannosidosis Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Research Inquiries

    30.4. The Business Research Company

    30.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2015-2020, $ Billion
  • Table 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Table 3: Global Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 4: Global Alpha Mannosidosis Market, Segmentation By Indication, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 5: Global Alpha Mannosidosis Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 6: Global Alpha Mannosidosis Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 7: Global Alpha Mannosidosis Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 8: Asia-Pacific, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 9: China, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 10: India, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 11: Japan, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 12: Australia, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 13: Indonesia, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 14: South Korea, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 15: Western Europe, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 16: UK, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 17: Germany, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 18: France, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 19: Eastern Europe, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 20: Russia, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 21: North America, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 22: USA, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 23: South America, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 24: Brazil, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 25: Middle East, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 26: Africa, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 27: CHIESI Farmaceutici SpA Financial Performance
  • Table 28: Nuo Therapeutics Financial Performance
  • Table 29: Zymenex Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2015-2020, $ Billion
  • Figure 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Figure 3: Global Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 4: Global Alpha Mannosidosis Market, Segmentation By Indication, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 5: Global Alpha Mannosidosis Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 6: Global Alpha Mannosidosis Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 7: Global Alpha Mannosidosis Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 8: Asia-Pacific, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 9: China, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 10: India, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 11: Japan, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 12: Australia, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 13: Indonesia, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 14: South Korea, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 15: Western Europe, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 16: UK, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 17: Germany, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 18: France, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 19: Eastern Europe, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 20: Russia, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 21: North America, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 22: USA, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 23: South America, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 24: Brazil, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 25: Middle East, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 26: Africa, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 27: CHIESI Farmaceutici SpA Financial Performance
  • Figure 28: Nuo Therapeutics Financial Performance
  • Figure 29: Zymenex Financial Performance
Global Psoriasis Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Psoriatic Arthritis Treatment Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Regenerative Medicine For Cartilage Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Radiopharmaceuticals Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Remdesivir Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Research Antibodies and Reagents Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Rituximab Biosimilars Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Respiratory Diseases Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Pharmaceutical API Manufacturing Global Market Report 2021 - By Therapy Area (Cardiovascular Disorders, Metabolic Disorders, Neurological Disorders, Oncology, Musculoskeletal Disorders, NSAIDs, Other Therapeutics Uses), By API Type (Chemical API, Biological API), By Drug Type (Innovative Drugs, Generic Prescription, Over-The-Counter (OTC) Drugs), COVID-19 Growth And Change
View Report
Pharmaceuticals Market - By Type (Pharmaceutical Drugs, Biologics), By Type Of Pharmaceutical Drugs (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorder Drugs, Central Nervous System Drugs, Oncology Drugs, Ophthalmology Drugs, Respiratory Diseases Drugs), By Type Of Biologics Drugs (Monoclonal Antibodies (MAbS), Therapeutic Proteins, Vaccines), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Generic Pharmaceuticals Global Market Report 2021 - By Therapy (CNS, Cardiovascular, Dermatology, Genitourinary/Harmonal, Respiratory, Rheumatology, Diabetes, Oncology), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Type (Biosimilar, Simple Generic, Super Generic), By Drug Delivery (Oral, Inectables, Dermal/Topical, Inhaler), COVID-19 Growth And Change
View Report
Anti-Hypertensive Drugs Global Market Report 2021 - By Therapeutics (Diuretics, Angiotensin Receptor Blockers (ARBs), Angiotensin Converting Enzyme (ACE) Inhibitors, Beta Blockers, Alpha Blockers, Calcium Channel Blockers, Renin Inhibitors, Vasodilators), By Disease Source (Primary Hypertension, Secondary Hypertension), By End Users (Hospitals, Clinics, Homecare), COVID-19 Impact And Recovery
View Report
Cell And Gene Therapy Global Market Report 2021 - By Product (Cell Therapy, Gene Therapy), By Application (Oncology, Dermatology, Musculoskeletal), By End User (Hospitals, Ambulatory Surgical Centers, Cancer Care Centers, Wound Care Centers), COVID-19 Growth And Change
View Report
Antiglaucoma Drugs Global Market Report 2021 - By Product Type (Alpha Agonist, Beta Blockers, Prostaglandin Analogs, Combined Medication), By Disease Condition Type (Open-Angle Glaucoma, Angle-Closure Glaucoma, Normal-Tension Glaucoma, Congenital Glaucoma), By Type (Hospital Prescription Drugs, Over-the-counter Drugs), COVID-19 Impact And Recovery
View Report
Anemia And Other Blood Disorder Drugs Global Market Report 2021 - By Type (Iron Deficiency Anemia, Chronic Kidney Disease Anemia, Sickle Cell Anemia, Aplastic Anemia), By Distribution Channel (Hospitals Pharmacy, Online Pharmacy, Pharmacy), By Route of Administration (Oral, Injectable), By Anemia Type (Microcytic (Low MCV), Normocytic (Normal MCV), Macrocytic (High MCV)), COVID-19 Impact And Recovery
View Report
Oral Biologics And Biosimilars Market - By Therapeutic Mechanism (Tumor Necrosis Factor-Alpha Inhibitors, Lymphocyte Modulators, Interleukin Inhibitors, GPCR (insulin, growth hormone, parathyroid hormone) Modulators, Immunostimulants, Others), By Disease (Diabetes, Arthritis & Chron`s Disease, Cancer, Infectious Diseases, Other Autoimmune Diseases, Others Diseases), By Molecule Type (Vaccines, Proteins & Peptides, Monoclonal Antibodies, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)